Funding Round
Neuralify raises €15M to accelerate FDA submission for AI EEG platform
Les Echos Entrepreneurs3/22/2026·03/22/26🌐 Europe
Summary
Paris-based Neuralify secured €15M from existing investors Cathay Innovation and Bpifrance, specifically earmarked for the FDA 510(k) submission process for their AI EEG interpretation platform. The FDA pathway targets the epilepsy monitoring and ICU brain surveillance indications where the platform has the strongest clinical evidence base.
Why it matters
FDA clearance for an AI EEG platform used in 120 hospitals would be one of the most significant clinical AI neurotech regulatory milestones in 2025-2026. Neuralify's 2-million-EEG annual throughput gives them an enormous real-world performance dataset to support the submission.
#EEG#AI Diagnostics#Neurodiagnostics#FDA#France
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in